AALL1732
OPEN TO ACCRUAL
Phase 3 Inotuzumab Ozogamicin for Newly Dx HR B ALL plus MPAL and Disseminated B LLy
APEC14B1
OPEN TO ACCRUAL
Project: Every Child A Registry, Eligibility Screening, Biology and Outcome Study
APEC1621SC
OPEN TO ACCRUAL
APEC1621_Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol